Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
Oragenics Announces Proposed Public Offering
SARASOTA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a company focused on developing unique,... Read more.
American Financial Group, Inc. Announces Changes to its Board of Directors
CINCINNATI–(BUSINESS WIRE)–American Financial Group, Inc. (NYSE: AFG) announced that its Board of Directors has elected Roger K. Newport as a director.... Read more.
Lemonade Announces Fourth Quarter and Full Year 2023 Financial Results
NEW YORK–(BUSINESS WIRE)–Lemonade, Inc. (NYSE: LMND) has released its fourth quarter and full year 2023 financial results by posting them to its website.... Read more.
Paysign to Host Fourth Quarter and Full Year 2023 Earnings Call
HENDERSON, Nev.–(BUSINESS WIRE)–Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings,... Read more.
Civitas Resources, Inc. Announces Share Repurchase From NGP
DENVER–(BUSINESS WIRE)–Civitas Resources, Inc. (NYSE: CIVI) (“Civitas” or the “Company”), today announced the execution of a definitive agreement... Read more.
Ryan Specialty Reports Fourth Quarter 2023 Results; Initiates Quarterly Dividend
– Total Revenue grew 22.5% year-over-year to $532.9 million – – Organic Revenue Growth Rate of 16.0% year-over-year – – Net Income... Read more.
NYSE Group Consolidated Short Interest Report
NEW YORK–(BUSINESS WIRE)–NYSE today reported short interest as of the close of business on the settlement date of February 15, 2024. SETTLEMENT DATE... Read more.
Civitas Announces Fourth Quarter and Full-Year 2023 Results
2024 Outlook Focused on Free Cash Flow and Cash Returns to Shareholders; Production Guidance Maintained with 7% Reduction in Capital DENVER–(BUSINESS WIRE)–Civitas... Read more.